BAKER BROS. ADVISORS LP – NGM Biopharmaceuticals, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$0
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+2.03%
quarter
NGM Biopharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -55.29K shares | -709K | $13.08 | 0 |
| Q2 2022 | share | Decrease | -81.05% | -236.50K shares | -3.74M | $12.82 | 55.29K |
| Q1 2022 | share | 0.00% | 0 shares | -718K | $15.25 | 291.80K | |
| Q4 2021 | share | 0.00% | 0 shares | -966K | $17.56 | 291.80K | |
| Q3 2021 | share | 0.00% | 0 shares | 380K | $21.02 | 291.80K | |
| Q2 2021 | share | 0.00% | 0 shares | -2.72M | $19.72 | 291.80K | |
| Q1 2021 | share | Increase | +173.69% | 185.18K shares | 5.25M | $29.07 | 291.80K |
| Q4 2020 | share | Decrease | -9.72% | -11.48K shares | 1.35M | $30.3 | 106.61K |
| Q3 2020 | share | Decrease | -5.06% | -6.3K shares | -577K | $15.91 | 118.1K |
| Q2 2020 | share | Decrease | -50.24% | -125.6K shares | -627K | $19.74 | 124.4K |
| Q1 2020 | share | 0.00% | 0 shares | -1.54M | $12.33 | 250K | |
| Q4 2019 | share | 0.00% | 0 shares | 1.16M | $18.49 | 250K | |
| Q3 2019 | share | 0.00% | 0 shares | -197K | $13.85 | 250K | |
| Q2 2019 | share | Increase | 0.00% | 250K shares | 3.66M | $14.64 | 250K |